Comparing Aspyra (OTCMKTS:APYI) and SOPHiA GENETICS (NASDAQ:SOPH)

Aspyra (OTCMKTS:APYI) and SOPHiA GENETICS (NASDAQ:SOPH) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings.

Institutional & Insider Ownership

31.6% of SOPHiA GENETICS shares are held by institutional investors. 23.9% of Aspyra shares are held by insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Aspyra has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Comparatively, SOPHiA GENETICS has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for Aspyra and SOPHiA GENETICS, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspyra	0	0	0	0	0.00
SOPHiA GENETICS	1	0	2	0	2.33

SOPHiA GENETICS has a consensus target price of $7.00, indicating a potential upside of 48.94%. Given SOPHiA GENETICS’s stronger consensus rating and higher probable upside, analysts clearly believe SOPHiA GENETICS is more favorable than Aspyra.

Profitability

This table compares Aspyra and SOPHiA GENETICS’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aspyra	N/A	N/A	N/A
SOPHiA GENETICS	-44.22%	-50.60%	-21.00%

Valuation and Earnings

This table compares Aspyra and SOPHiA GENETICS”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspyra	N/A	N/A	N/A	N/A	N/A
SOPHiA GENETICS	$77.27 million	4.17	-$79.00 million	($0.51)	-9.22

Aspyra has higher earnings, but lower revenue than SOPHiA GENETICS.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.